From neurodegeneration to neurohomeostasis: The roles of ubiquitin

Drug News and Perspectives

Volumn 16, Issue 2, 2003, Pages 103-108

  Mayer, R John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR; NEUROTRANSMITTER RECEPTOR; OPIATE RECEPTOR; RETINA S ANTIGEN; UBIQUITIN; CYSTEINE PROTEINASE; LIGASE; MULTIENZYME COMPLEX; PROTEASOME; UBIQUITIN PROTEIN LIGASE;

ALCOHOL LIVER DISEASE; ALZHEIMER DISEASE; ASTROCYTOMA; COGNITIVE DEFECT; DEGENERATIVE DISEASE; HOMEOSTASIS; IMMUNOCYTOCHEMISTRY; LEWY BODY; MEMORY; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; PARKINSON DISEASE; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; TRANSGENICS; AGING; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY; PRION DISEASE;

AGING; ALZHEIMER DISEASE; CYSTEINE ENDOPEPTIDASES; HOMEOSTASIS; HUMANS; LEWY BODIES; LIGASES; MEMORY; MULTIENZYME COMPLEXES; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; PRION DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 0037933427     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.2.829327     Document Type: Review

References (54)

1. Glickman, M.H. and Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 2002, 82: 373-428.
2. Jentsch, S. and Pyrowolakis, G. Ubiquitin and its kin: How close are the family ties? Trends Cell Biol 2000, 10: 335-42.
3. Pickart, C.M. Ubiquitin in chains. Trends Biochem Sci 2000, 25: 544-8.
4. Thrower, J.S. et al. Recognition of the poly-ubiquitin proteolytic signal. Embo J 2000, 19: 94-102.
5. Kloetzel, P.M. Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2001, 2: 179-87.
6. Lake, M.W. et al. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 2001, 414: 325-9.
7. Katzmann, D.J. et al. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001, 106:145-55.
8. Shih, S.C. et al. Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis. Nat Cell Biol 2002, 4:389-93.
9. Ohsumi, Y. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001, 2: 211-6.
10. Jesenberger, V. and Jentsch, S. Deadly encounter: Ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 2002, 3: 112-21.
11. Mori, H. et al. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987, 235: 1641-4.
12. Doherty, F.J. et al. A putative protein-sequestration site involving intermediate filaments for protein degradation by autophagy. Studies with microinjected purified glycolytic enzymes in 3T3-LI cells. Biochem J 1987, 241: 793-800.
13. Earl, R.T. et al. A putative protein-sequestration site involving intermediate filaments for protein degradation by autophagy. Studies with transplanted Sendai viral envelope proteins in HTC cells. Biochem J 1987, 241: 809-15.
14. Laszlo, L. et al. The latent membrane protein-1 in Epstein-Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein 70 in lysosomes oriented around the microtubule organizing centre. J Pathol 1991, 164: 203-14.
15. Johnston, J.A. et al. Aggresomes: A cellular response to misfolded proteins. J Cell Biol 1998, 143: 1883-98.
16. Lowe, J. et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1998, 155: 9-15.
17. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997, 90: 537-48.
18. Morishima-Kawashima, M. et al. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 1993, 10: 1151-60.
19. Lennox, G. et al. Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases. Neurosci Lett 1988, 94: 211-7.
20. Lennox, G. et al. Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989, 52: 1236-47.
21. Lennox, G. et al. Diffuse Lewy body disease: An important differential diagnosis in dementia with extrapyramidal features. Prog Clin Biol Res 1989, 317: 121-30.
22. Lowe, J. et al. A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett 1989, 94: 203-10.
23. Laszlo, L. et al. Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol 1992, 166: 333-41.
24. Probst, A. et al. Perisomatic granules of hippocampal CAI neurones in Alzheimer's disease, pre-Alzheimer's disease and Pick's disease: An overlooked pathological entity. In: Neuropathology and Genetics of Dementia (Vol. 487) Tolnay, M. and Probst, A. (Eds.). Kluwer Academic/Plenum Publishers, New York 2001, 187-98.
25. + channel (ENaC) by ubiquitination. Embo J 1997, 16: 6325-36.
26. Low, P. et al. Related organelles of the endosome-lysosome system contain a different repertoire of ubiquitinated proteins in Sf9 insect cells. FEBS Lett 1995, 368: 125-31.
27. Nixon, R.A. et al. The neuronal endosome-lysosome system in Alzheimer's disease. J Alzh Dis 2001, 3: 97-107.
28. Stenoien, D.L. et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 1999, 8: 731-41.
29. Warrick, J.M. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 1999, 23: 425-8.
30. Chung, K.K. et al. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 2001, 24(11 Suppl.), S7-14.
31. Magin, T.M. et al. Lessons from keratin 18 knockout mice: Formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J Cell Biol 1998, 140: 1441-51.
32. Safar, J. and Prusiner, S.B. Molecular studies of prion diseases. Prog Brain Res 1998, 117: 421-34.
33. Matsuura, T. et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997, 15:74-7.
34. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392: 605-8.
35. Farrer, M. Lewy bodies and Parkinsonism in families with Parkin mutations. Ann Neurol 2001, 50: 293-300.
36. Wilson, S.M. Synaptic defects in ataxia mice result from a mutation in Uspl4 encoding a ubiquitin-specific protease. Nature Genetics 2002.
37. DiAntonio, A. et al. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 2001, 412: 449-52.
38. Hegde, A.N. and DiAntonio, A. Ubiquitin and the synapse. Nat Rev Neurosc 2002, 3: 854-6.
39. Oh, C.E. et al. Bendless, a Drosophila gene affecting neuronal connectivity, encodes a ubiquitin-conjugating enzyme homolog. J Neurosci 1994, 14: 3166-79.
40. Bedford, F.K. et al. GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-I. Nat Neurosci 2001, 4: 908-16.
41. Buttner, C. et al. Ubiquitination precedes internalization and proteolytic cleavage of plasma membrane-bound glycine receptors. J Biol Chem 2001, 276: 42978-85.
42. Shenoy, S.K. et al. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 2001, 294: 1307-13.
43. Chaturvedi, K. et al. Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. J Biol Chem 2001, 276: 12345-55.
44. Rezvani, K. et al. Proteasomal interactors control activities as diverse as the cell cycle and glutaminergic neurotransmission. Biochem Soc Transact 2003, 31: 1-4.
45. Kammermeier, P.J. and Ikeda, S.R. A role for seven in absentia homolog (Siahla) in metabotropic glutamate receptor signaling. BMC Neurosci 2001, 2: 15.
46. Cohen-Cory, S. The developing synapse: Construction and modulation of synaptic structures and circuits. Science 2002, 298: 770-80.
47. Silva, J. and Josselyn, S.A. The molecules of forgetfulness. Nature 2002, 418: 929-30.
48. Mayer, R.J. Molecular turnover and memory. Nature 1985, 313: 636.
49. Jiang, C. and Schuman, E.M. Regulation and function of local protein sysnthesis in neuronal dendrites. Trends Biochem Sci 2002, 27: 506-13.
50. Hicke, L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2001, 2: 195-201.
51. Mitsiades, N. et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci USA 2002, 99: 14374-9.
52. Moss, A. et al. A role of the ubiquitin-proteasome system in neuropathic pain. J Neurosci 2002, 22: 1363-72.
53. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298: 789-91.
54. Verma, R. et al. Role of RpnII metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298: 611-5.